Search
for
Sort by
Research 91–120 of 1000+
- BH14 Irish dermatologists’ experience with Janus kinase inhibitors in alopecia areata
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- A Single Subcutaneous Dose of BMD-1141 Stimulates Hair Regrowth Comparable to Daily, High-Dose Ruxolitinib in a Mouse Model of Alopecia Areata.
- POS0080 TOFACITINIB TREATMENT IN CHILDREN WITH RHEUMATIC DISEASES: SINGLE-CENTER EXPERIENCE
- MODERN BIOLOGICAL TREATMENT METHODS FOR ALOPECIA AREATA: A COMPREHENSIVE REVIEW
- Low-dose tofacitinib for treating patients with severe alopecia areata: an efficient and cost-saving regimen
- Real-Life Effectiveness and Tolerance of Baricitinib for the Treatment of Severe Alopecia Areata with 1-Year Follow-Up Data
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata
- 455 Molecular correlation with clinical outcomes in an open label clinical trial of oral tofacitinib in patients with alopecia areata
- Alopecia areata and ritlecitinib: Unravelling response trajectories
- A retrospective review of paediatric alopecia areata cases seen in a tertiary institution in Singapore
- Treatment of severe alopecia areata with baricitinib
- Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents
- Alopecia areata flare patterns in children and young adults while on systemic tofacitinib
- Evidence for the off-label use of tofacitinib in alopecia areata
- Oral and Topical Janus Kinase Inhibitors in Patients With Cutaneous T‐Cell Lymphoma: A Real‐World Single‐Center Experience
- When hair dig into the brain, JAKi , may help!
- The Frontal Fibrosing Alopecia Treatment Dilemma
- Quoi de neuf en dermatologie pédiatrique ?
- Treatment of Lichen Planopilaris and Frontal Fibrosing Alopecia: A Retrospective, Real-Life Analysis in a Tertiary Center in Germany
- 63-Year-Old Female with Diffuse Thinning of the Hair
- Seborrheic Dermatitis Revisited: Pathophysiology, Diagnosis, and Emerging Therapies—A Narrative Review
- Alopecia Areata of the Nails: Diagnosis and Management
- Pyroptosis in Alopecia Areata: Synthesizing Emerging Hypotheses and Charting a Path to New Therapies
- JAK1 Signaling Is Involved in the Induction of Mechanical Alloknesis in Atopic Dermatitis
- Case Series: Gene Expression Analysis in Canine Vogt-Koyanagi-Harada/Uveodermatologic Syndrome and Vitiligo Reveals Conserved Immunopathogenesis Pathways Between Dog and Human Autoimmune Pigmentary Disorders
- A pilot study of 2% tofacitinib cream with narrowband ultraviolet B for the treatment of facial vitiligo
- Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Upadacitinib for the Management of Alopecia Totalis and Subtotalis in Pediatric Patients: A Case Series